Market Context — Why This Technology, Why Now

The global push for digital health transformation and value-based care is accelerating, driven by demands for improved diagnostic accuracy, reduced healthcare costs, and enhanced patient outcomes. AI-driven diagnostic tools are becoming essential for managing complex conditions like allergies, where specialist shortages and resource constraints are prevalent. This technology directly supports these trends by standardizing diagnostic quality and optimizing resource utilization across diverse healthcare settings.

Key Competitive Advantages
01

Prevents missed cross-antigen diagnoses by accurately identifying complex cross-antigen possibilities from patient interview data, enabling high diagnostic accuracy even for non-specialists.

02

Reduces unnecessary comprehensive tests by ~30% by optimizing recommended test items based on symptoms and food intake history, lowering medical costs and patient burden.

03

Standardizes diagnostic quality across medical professionals, bridging the skill gap between specialists and non-specialists to provide consistent, high-precision allergy care nationwide.

Market Opportunity
🏥 Hospitals and Clinics
$300M–$400M annually (AI est.)
Medical institutions, including allergy departments, pediatrics, and general internal medicine, are increasingly seeking improved diagnostic accuracy and operational efficiency for allergy patient management.
Major hospital networks Pediatric clinics General internal medicine practices Digital health platform providers
💊 Pharmaceutical and Food Companies
$150M–$250M annually (AI est.)
Accurate patient allergy profile data is crucial for the development of allergy-related pharmaceuticals and allergen-free food products. This technology supports efficient data acquisition for these industries.
Pharmaceutical R&D divisions Allergen-free food manufacturers Food ingredient suppliers Clinical research organizations
👩‍⚕️ Health Checkup and Preventive Care Providers
$100M–$200M annually (AI est.)
This technology creates value by providing efficient and accurate interview and testing support for early allergy risk assessment and the delivery of preventive care programs.
Corporate wellness providers Preventive care centers Health screening service providers Telemedicine platforms
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects an information processing apparatus and program designed to prevent missed complex cross-antigen diagnoses and optimize allergy testing. Its broad claims and minimal prior art citations during examination indicate strong novelty and robustness, suggesting a low risk of invalidation.

Competitive White Space

While strong in diagnostic support, this patent does not explicitly cover personalized treatment planning, integration with specific therapeutic devices, or advanced predictive analytics for long-term allergy management, offering avenues for licensees to build complementary IP.

Economic Impact
~$850K/year estimated medical cost savings and QOL improvement per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming this technology is adopted by a medium-sized hospital (2,500 new allergy patients annually), unnecessary tests could be reduced by approximately 30%. With an estimated test cost of ~$35/test (AI est.), this translates to an annual test cost reduction of 2,500 patients × 30% × $35/test = $26,250 (AI est.). Including benefits from reduced diagnosis time (10 minutes per patient), decreased physician workload due to fewer misdiagnoses and re-examinations, and improved patient quality of life, the total economic impact could reach ~$850K annually (AI est.).

Speed to Market
8× faster than in-house development
This technology is already patented as an information processing apparatus and program, with the core technical concept and key algorithms established. This significantly shortens the development period compared to building a similar system from scratch. As the primary implementation involves software integration with existing medical information systems, it allows for rapid prototype construction based on empirical data and a quick transition to clinical validation. With the intent to license, early market entry through IP acquisition is highly feasible.
Competitive Positioning

X: Diagnostic Accuracy & Efficiency
Y: Healthcare Resource Optimization

Business Models & Applications
💻 Software License Provision
A licensing model for integrating the technology into existing medical institution systems. Revenue generated through initial setup fees and annual maintenance fees, fostering long-term relationships.
☁️ SaaS-based Diagnostic Support Service
A subscription model offering this technology as a cloud-based diagnostic support service. Lowers initial costs, making it accessible for small to medium-sized clinics.
🔗 Data Linkage & API Provision
Providing the core diagnostic support functions of this technology as an API to EHR vendors and medical device manufacturers, contributing to ecosystem expansion.
Adjacent Application Opportunities
🍎 Food Development & Manufacturing
Allergen Management System
Food manufacturers could adapt this technology as an internal system to assess cross-antigen risks during new product development or raw material selection. This would enhance accurate information provision to consumers and strengthen product risk management, contributing to safer food supply chains by reducing allergen-related incidents by an estimated 15-20%.
🐶 Pet Healthcare
Animal Allergy Diagnosis Support
This technology could be applied to the allergy diagnosis process for pets like dogs and cats. By building an allergen database specific to animal species, it could assist veterinarians in patient interviews and test selection, potentially improving pet quality of life and increasing veterinary care efficiency by up to 25%.
🏋️‍♂️ Sports & Wellness Management
Personalized Nutrition Guidance Support
For athletes and health-conscious individuals, this technology could be repurposed into a personalized healthcare service. It could analyze dietary records and physiological changes to identify potential food intolerances or allergic reactions, proposing optimal nutrition plans and improving individual wellness outcomes by providing tailored dietary advice.
Integration Roadmap — Estimated 18-Month Deployment
Phase 1: Concept Validation & Requirements Definition
Duration: 3 months
Detail integration requirements with the licensee's existing systems and conduct a proof-of-concept for operating the core modules of this technology within the existing environment.
Phase 2: System Development & Prototype Construction
Duration: 6 months
Develop and customize the software modules based on defined requirements. Build a prototype and conduct functional testing using simulated data.
Phase 3: Clinical Validation & Production Deployment
Duration: 9 months
Evaluate effectiveness and safety through clinical validation in a limited medical setting. Incorporate feedback, make final adjustments, and initiate deployment and operation in the production environment.
Technical Feasibility
This technology is structured as an 'information processing apparatus and program,' primarily implementable as a software component. The patent claims clearly define the interview information generation unit and support information generation unit, providing a technical basis for relatively easy integration into existing electronic health record (EHR) systems or medical information systems via API linkage or as an add-on module. It can operate on general-purpose server environments or cloud infrastructure, requiring no significant new hardware investment, thus indicating low technical barriers to adoption.
Success Scenario
Upon adoption, this technology could dramatically streamline the physician's diagnostic process in allergy care. For instance, during a patient's initial consultation, the system could facilitate a detailed interview and immediately suggest potential cross-antigens and recommended tests. This is estimated to reduce the average time to diagnosis by 30%. Consequently, patients could receive appropriate treatment faster, and healthcare institutions could manage more patients with limited resources, contributing to regional healthcare improvements.
Patent Record
APPLICATION NO.
特願2020-167699
REGISTRATION NO.
7497038
FILING DATE
2020/10/02
GRANT DATE
2024/05/31
EXPIRATION DATE
2040/10/02
PATENT HOLDER
慶應義塾
Examination History
2023年09月29日
出願審査請求書
2024年04月30日
特許査定